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Modelado Molecular y Bioinforma´tica, Escuela Superior de Medicina, Instituto Polite´cnico Nacional, Mexico City, MexicoABSTRACT We performed protein pKa calculations and molecular dynamics (MD) simulations of the calcium pump (sarco-
plasmic reticulum Ca2þ-ATPase (SERCA)) in complex with phospholamban (PLB). X-ray crystallography studies have sug-
gested that PLB locks SERCA in a low-Ca2þ-affinity E2 state that is incompatible with metal-ion binding, thereby blocking the
conversion toward a high-Ca2þ-affinity E1 state. Estimation of pKa values of the acidic residues in the transport sites indicates
that at normal intracellular pH (7.1–7.2), PLB-bound SERCA populates an E1 state that is deprotonated at residues E309 and
D800 yet protonated at residue E771. We performed three independent microsecond-long MD simulations to evaluate the struc-
tural dynamics of SERCA-PLB in a solution containing 100 mM Kþ and 3 mM Mg2þ. Principal component analysis showed that
PLB-bound SERCA lies exclusively along the structural ensemble of the E1 state. We found that the transport sites of PLB-
bound SERCA are completely exposed to the cytosol and that Kþ ions bind transiently (%5 ns) and nonspecifically (nine different
positions) to the two transport sites, with a total occupancy time of Kþ in the transport sites of 80%.We propose that PLB binding
to SERCA populates a novel (to our knowledge) E1 intermediate, E1,Hþ771. This intermediate serves as a kinetic trap that con-
trols headpiece dynamics and depresses the structural transitions necessary for Ca2þ-dependent activation of SERCA. We
conclude that PLB-mediated regulation of SERCA activity in the heart results from biochemical and structural transitions that
occur primarily in the E1 state of the pump.INTRODUCTIONThe calcium pump (sarcoplasmic reticulum Ca2þ-ATPase
(SERCA)), a member of the P-type ATPase family, is an
integral membrane protein that is responsible for the
active transport of Ca2þ from the cytosol into the sarco-
plasmic reticulum (SR) lumen of heart and muscle cells
(1). Relaxation occurs when SERCA pumps two Ca2þ
ions into the SR lumen using energy derived from
hydrolysis of one ATP molecule and the countertransport
of two protons (2,3). Closely related SERCA isoforms
are also responsible for pumping Ca2þ into the endo-
plasmic reticulum of virtually all nonmuscle cells, poten-
tiating a myriad of Ca2þ-dependent cellular activation
processes.
In cardiac muscle, SERCA activity is regulated by phos-
pholamban (PLB), a small membrane protein that inhibits
SERCA by decreasing its apparent Ca2þ affinity (4,5). Inhi-
bition of SERCA is relieved physiologically either at
elevated Ca2þ levels (6) or by phosphorylation of PLB at
S16 by protein kinase A (PKA) (7), reversing calcium trans-
port inhibition and greatly augmenting cardiac output (8).
Initial attempts to modulate the SERCA-PLB interaction re-
sulted in improved cardiac function in heart-failure animal
models (9–13). A deeper understanding of the structural ba-Submitted November 3, 2014, and accepted for publication March 4, 2015.
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design of small-molecule and gene therapies for the treat-
ment of human heart failure.
High-resolution spectroscopy, engineered chemical cross-
linking, and extensive site-directed mutagenesis have shown
that the transmembrane (TM) domain of PLB binds to a large
groove formed around TM helices TM2, TM4, TM6, and
TM9 of SERCA (14–20). Fluorescence resonance energy
transfer (FRET) and NMR spectroscopy studies have shown
that in the bound complex, the cytosolic domain of PLB
natively undergoes a dynamic equilibrium between inhibi-
tory (T) and noninhibitory (R) structural states, and that a
shift between these states is essential for regulation of
SERCA activity (21–24). Although the structural equilib-
rium of PLB is fundamental for SERCA regulation, the
atomistic mechanisms by which the T state inhibits SERCA
and the phosphorylation-induced R state relieves inhibition
remain unknown. Akin et al. (25,26) recently reported a
0.28-nm-resolution crystal structure of SERCA1a bound
to the gain-of-function, cross-linkable PLB mutant PLB4
(N27A, N30C, L37A, and V49G-PLB) (25) and in the
absence of Ca2þ (26). Although the crystal structure is
missing the regulatory cytosolic segment of PLB (residues
M1–Q23), it yielded important data on the structural basis
of SERCA inhibition by the TM domain of PLB (27).
For instance, the crystal structure also revealed that PLB4
binding alters the structure of SERCA around residueshttp://dx.doi.org/10.1016/j.bpj.2015.03.004
1698 Espinoza-Fonseca et al.V795–A804, resulting in a collapsed Ca2þ binding site I.
Based on these observations, it was proposed that PLB in-
hibits SERCA by populating an E2 state that is incompatible
with metal-ion binding (26).
Investigators have traditionally assumed that PLB stabi-
lizes SERCA in E2, as suggested by kinetics, cross-linking,
and co-immunoprecipitation. However, the assumption that
PLB4 binding stabilizes SERCA in an E2 state is problem-
atic for three reasons. 1) The structure of SERCA in the PLB
complex is remarkably similar to the structure of sarcolipin-
bound SERCA, which was assigned as an E1 intermediate
state due to headpiece structure and Mg2þ binding to the
transport sites (28,29). 2) The gating residue E309 points
away from residues V304 and A305, allowing the transport
sites to be exposed to the cytosol—a feature that is charac-
teristic of E1, but not of E2 (30,31). 3) Experimental studies
have shown that PLB binding decreases SERCA’s apparent
affinity for Ca2þ by 2- to 3-fold in the submicromolar range
(32). This moderate decrease in apparent Ca2þ affinity is
incompatible with the millimolar-Ca2þ-affinity E2 state of
the pump (33).
Two models have been proposed to describe the physical
mechanism of PLB regulation: the dissociation model
and the subunit model. According to the dissociation
model, PLB dissociates from SERCA to relieve inhibition,
whereas in the subunit model, inhibition of SERCA is
relieved by structural rearrangements within the SERCA-
PLB complex, not by dissociation. Spectroscopic measure-
ments obtained with fluorescent and paramagnetic probes
have allowed direct detection of the SERCA-PLB interac-
tion in live cells, endoplasmic reticulum membranes, and
reconstituted vesicles, supporting the subunit model, with
a subtle complex rearrangement in high Ca2þ or PLB phos-
phorylation (34–36). Cross-linking studies have been inter-
preted as supporting the dissociation model, but are also
consistent with a structural rearrangement of the inhibitory
complex (15,17). Major questions remain regarding the na-
ture of the inhibitory interactions between SERCA and
PLB: Does PLB-bound SERCA resolved in the crystal
structure represents an E1 or an E2 state of the pump?
How does PLB binding inhibit Ca2þ binding in the trans-
port sites? What step(s) along the catalytic cycle of the
pump is inhibited by PLB? To address these questions,
we used the crystal structure of SERCA-PLB4 to obtain
a full-length structure of SERCA bound to the inhibitory
T state conformation of wild-type (WT) PLB, i.e., with
the cytosolic helix of PLB perpendicular to the lipid bilayer
normal. We used this model to perform three independent 1
ms MD simulations of the complex in the absence of Ca2þ
and in a solution containing physiologically appropriate
concentrations of other ions (100 mM Kþ, 3 mM Mg2þ,
and 110 mM Cl). Finally, we determined the structural
characteristics of PLB-bound SERCA by comparing the
trajectories of the complex with those of the E1 and E2
states of the pump.Biophysical Journal 108(7) 1697–1708MATERIALS AND METHODS
Protein pKa calculations
We used PROPKA 3.1 (37–40) to calculate the pKa values of acidic resi-
dues in the transport sites of SERCA. PROPKA estimates the empirical
pKa values of ionizable groups in proteins and protein-ligand complexes
based on the 3D structure, and benefits from explicitly incorporating the
Coulombic interactions that arise from mutually titrating residues via the
Tanford-Roxby procedure (41). PROPKA has previously been used to
determine the protonation states of acidic residues in other P-type
ATPases, e.g., the Naþ-Kþ ATPase (42,43). We calculated the pKa values
in the E1 state using eight crystal structures retrieved from the Protein
Data Bank (PDB): 1SU4, 1VFp, 3W5A, 3W5B, 3AR2, 1T5S, 4H1W, and
3N8G. We also performed pKa calculations on seven crystal structures of
the E2 state: 1IWO, 2AGV, 2EAR, 2EAT, 2C8K, 3W5C, and 2EAU. In
addition, we used the crystal structure of SERCA-PLB (PDB: 4KYT) to es-
timate the pKa values of the acidic residues in the complex. A list of the
ligands and biochemical state represented by each crystal structure can
be found in Table S1 in the Supporting Material.Modeling of the full-length SERCA-PLB complex
The initial atomic model of WT PLB bound to SERCA was constructed
using the crystal structure of SERCA-PLB4 as a template (26). Here,
we modeled the complex in two stages: first, we reconstructed four loops
of SERCA that were not resolved in the crystal structure of the complex:
E45–S48, E79–T86, A241–D245, and N280–I289. Loop reconstruction
was performed using MODELER (44). We used the crystal structure of
recombinant E1,Mg2þ (29) as a template to reconstruct the missing loops
of PLB4-bound SERCA, because the structure of the TM domain is virtu-
ally identical between the two structures (root mean-square deviation
(RMSD) ¼ 0.1 nm), and because TM alignment with E2 was especially
poor in the regions where the loops are missing in the crystal structure
of SERCA-PLB (Fig. S1). Second, we modeled the structure of the TM
domain of rabbit PLB using the coordinates of dog PLB4 bound to
SERCA. Only residues A27, C30, A37, and G49 of PLB4 were changed
to N27, N30, L37, and V49 to match the sequence of rabbit PLB (Fig. S2).
We constructed the structure of the cytosolic domain of PLB using model
14 of the NMR ensemble of the rabbit AFA-PLB mutant (PDB: 2KB7)
(45). Details regarding the selection of the most suitable PLB structure
and modeling of full-length PLB are provided in Supporting Materials
and Methods.Setting up SERCA-PLB for simulation
We adjusted the ionization states of the acidic residues of Ca2þ-binding
sites to match the results from our pKa calculations. Therefore, residues
E309 and D800 were kept ionized, whereas residues E771 and E908
were modeled as protonated. In addition, we adjusted the pKa of other
ionizable residues to a pH value of ~7.2. The complex was inserted in a
pre-equilibrated 12  12 nm bilayer of palmitoyl-2-oleoyl-sn-glycerol-
phosphatidylcholine (POPC). This initial system was solvated using
TIP3P water molecules with a minimum margin of 1.5 nm between the
protein and the edges of the periodic box in the z axis. Kþ, Mg2þ, and
Cl ions were added to produce concentrations of 100 mM, 3 mM, and
110 mM, respectively. The size of each protein/lipid/water/ions system
was ~220,000 atoms. CHARMM36 force-field topologies and parameters
were used for the protein (80), lipid (81), water, Kþ, and Cl. In addition,
we used a set of new CHARMM parameters for Mg2þ developed by Allne´r
et al. (82). This new set of parameters for Mg2þ was chosen to correct the
Mg2þ-water exchange rate, as previous parameters do not correctly capture
the water exchange kinetics between the first coordination shell and bulk
water (82).
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We used three crystal structures (PDB 1IWO (48), 2AGV (49), and 3W5C
(29)) to simulate the structural dynamics of E2 SERCA. Residues E309,
E771, and E908 were modeled as protonated, whereas D800 was left depro-
tonated. We adjusted the pH of the system to a value of 7.2 by adjusting the
side-chain ionization states using PROPKA (39). Each protein system was
inserted into a pre-equilibrated 12  12 nm POPC bilayer. This initial sys-
tem was further solvated using TIP3P water molecules with a minimum
margin of 1.5 nm between the protein and the edges of the periodic box
in the z axis. Finally, Kþ, Mg2þ, and Cl ions were added in the same con-
centrations used for the SERCA-PLB systems. The size of each protein/
lipid/water/ions system was ~220,000 atoms. CHARMM36 force-field to-
pologies and parameters with CMAP correction (80,81) were used for the
protein, lipid, water, and ions.Molecular dynamics simulations
We performed molecular dynamics (MD) simulations of SERCA-PLB and
E2 SERCA using the program NAMD 2.9 (52) with periodic boundary con-
ditions (53), particle mesh Ewald (54,55), a nonbonded cutoff of 0.9 nm,
and a 2 fs time step. The NPT ensemble was maintained with a Langevin
thermostat (310 K) and an anisotropic Langevin piston barostat (1 atm).
Fully solvated systems were first subjected to energy minimization, and
the systems were then gradually warmed up for 200 ps. This procedure
was followed by 10 ns of equilibration, with backbone atoms harmonically
restrained using a force constant of 1000 kcal mol1 nm2. We performed
six independent 1 ms MD simulations (three of SERCA-PLB and three of
E2 SERCA).Cartesian principal component analysis
We used Cartesian principal component analysis (cPCA) to compare the
structural ensembles of the SERCA-PLB, E1, and E2 states of the pump.
cPCA uses the actual dynamics of the protein to generate the appropriate
collective coordinates that capture the important structural and dynamic
features of the native states of the protein (56). For cPCA, we aligned
SERCA structures using the 10-helix TM domain as a reference. We had
three purposes in selecting the TM domain as a reference: 1) to determine
whether E1 and E2 occupy different structural spaces; 2) to show that E1
and E2 do not spontaneously interchange in the timescales used in this
study; and 3) to illustrate the structural dynamics of the headpiece intrinsic
to E1 and E2 states. We used Carma (57) to perform cPCA.TABLE 1 Predicted pKa values of acidic residues in the
transport sites of SERCA
State E309 E771 D800 E908
E1 (x ray)a 5.95 1.0 3.95 0.7 1.4 5 0.6 8.85 0.2
E2 (x ray)a 8.65 0.4 10.75 0.1 7.5 5 0.2 10.05 0.3
E2 (MD)a,c 9.15 0.3 10.15 0.2 5.5 5 0.1 10.75 0.3
SERCA-PLB (x ray)b 4.9 9.7 6.2 8.4
SERCA-PLB (MD)a,c 5.45 0.3 9.25 0.2 6.1 5 0.1 7.95 0.2
aReported values are mean5 SE.
bpKa values calculated using a single crystal structure.
cValues calculated at the end of 20 ns MD simulations; n ¼ 5.RESULTS
Estimation of pKa values of acidic residues in the
transport of PLB-bound SERCA
The acidic residues E309, E771, and D800 are essential for
metal-ion binding and occlusion in transport sites (58). In
particular, changes in the protonation states of E309 and
E771 are crucial for the functional transition of SERCA at
physiological conditions. For instance, deprotonation of
E309 is required for the transition from E2 to E1
(31,59,60), and ionization of E771 is necessary to produce
a competent transport site I in E1 (61). Thus, we performed
empirical pKa calculations of these residues using the crys-
tal structure of SERCA-PLB (PDB code: 4KYT) and
compared the values against high-resolution crystal struc-
tures of the E1 and E2 states (Table S1). Although the crys-tal structures of E1 and E2 were crystallized with one or
more bound ligands and under different conditions, experi-
ments indicate that the forward and reverse E2-E1 transition
is accompanied by the release and binding of two protons,
respectively. Therefore, analysis of multiple crystal struc-
tures should be able to capture the protonation states
inherent to E1 and E2, and thus help to determine whether
PROPKA is sufficiently robust to capture protonation states
consistent with experimental data. The pKa values for trans-
port-site residues calculated from individual crystal struc-
tures are shown in Table S2.
Predicted pKa values of crystal structures of E2 SERCA
indicate that at normal intracellular pH (7.1–7.2 (62)), res-
idues E309, E771, and E908 are protonated. In the E2 state,
D800 has a mean pKa value of 7.5, implying that this res-
idue is in equilibrium between protonated and deprotonated
states at physiological pH (Table 1). Musgaard et al. (63)
found that among charged residues in the transport sites,
only D800 is likely to be deprotonated in E2. Hence, we
performed additional pKa calculations on MD-relaxed
structures of the E2. We found that D800 is deprotonated
in solution, in agreement with previous calculations
(Table 1). pKa calculations also indicated that only residues
E309, E771, and D800 are deprotonated in the E1 state of
SERCA (Table 1). Therefore, E2 is protonated at E309,
E771, and E908, whereas E1 is protonated only at E908.
These findings are in excellent agreement with experi-
mental data showing that the transition from E2 to E1 is
coupled with the release of two Hþ from the transport sites
(2). These findings indicate that despite the inherent limi-
tations of the model (approximate titration state/pKa
assignments, implicit solvent limitations, and the use of
static structures), PROPKA is sufficiently robust to predict
the protonation states that are characteristic of E1 and E2
SERCA.
Next, we calculated the pKa values of the acidic residues
in the transport sites of PLB-bound SERCA. We found
that the acidic residues E908 and E771 are protonated at
physiological pH (Table 1). This protonation pattern was re-
produced in pKa calculations performed using relaxed struc-
tures obtained from independent 20 ns MD simulations
of the complex in a fully solvated environment (Table 1).
During the 20 ns trajectories, we found that the positionBiophysical Journal 108(7) 1697–1708
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compared with crystal structures (RMSD % 0.07 nm).
This observation complements the pKa calculations and in-
dicates that in the absence of Ca2þ, E771 and E908 are pro-
tonated in PLB-bound SERCA.Structural dynamics of SERCA-PLB in solution
We performed three independent 1 ms MD simulations of
the complex to determine the structural stability and dy-
namics of PLB-bound SERCA protonated at E771 and
E908. The structures of the initial model as SERCA-PLB,
as well as the structure of the complex at the end of each
MD simulation, are shown in Fig. 1 A. We calculated the
backbone RMSD for each functional domain of SERCA
and PLB to determine the time-dependent structural dy-
namics of the complex in the 1 ms trajectories (Fig. 1 B).
At the beginning of each simulation, the structure of the
10-helix TM domain of PLB-bound SERCA underwent a
0.13 nm drift in the picosecond timescale (Fig. 1 B).
This modest change in RMSD is attributed to the relaxation
of the TM domain in a lipid/water environment. After
this rapid relaxation period, the RMSD values remained
virtually unchanged. These observations indicate that the
structural arrangement of the TM domain observed in our
trajectories is very similar to that determined by x-ray
crystallography. Conversely, we observed a large variability
in the RMSD values for each domain in the cytosolic head-
piece of SERCA-PLB (Fig. 1 B). These findings are in line
with previous studies showing that the cytosolic headpieceFIGURE 1 Structural dynamics of SERCA-PLB. (A) Initial and MD-
relaxed structures of the SERCA-PLB complex embedded in a lipid bilayer
(yellow) and water (blue). SERCA is colored according to its four func-
tional domains: N (green), P (blue), A (red), and TM (gray). PLB is shown
in magenta. (B) Time-dependent RMSD evolution of SERCA domains and
full-length PLB in SERCA-PLB. The RMSD of the TM domain of SERCA
and PLB was calculated using backbone alignment for TM helices of the
pump. The RMSD of N, P, and A domains was calculated by aligning the
backbone of the cytosolic headpiece with the structure at the beginning
of each trajectory. To see this figure in color, go online.
Biophysical Journal 108(7) 1697–1708of SERCA is inherently flexible at physiological conditions
(64–68).
The root mean-square fluctuation (RMSF) values of the
main-chain Ca atoms show that the TM helix of PLB in
the complex (residues A24–L51) has very low mobility
in the complex (Fig. 2 A) and that it exclusively populates
an a-helix structure in the microsecond timescale
(Fig. S3). In addition, RMSD plots show that the TM helix
rapidly settles a plateau around 0.2 nm in all three trajec-
tories (Fig. S4), indicating that the TM helix converged to
a position that is virtually identical to that in the crystal
structure. Indeed, 77% 5 2% of the native contacts found
in the crystal structure of SERCA-PLB4 are present in all
three trajectories of the WT PLB-bound complex (Fig. 2
B). Therefore, our simulations validate previous biochem-
ical and crystallographic studies suggesting that PLB4
binds to SERCA in a manner similar to that observed for
WT PLB (25,26).
We found that although the cytosolic helix of PLB
(residues E2–S16) was very mobile (Figs. 2 and S4), this
segment populated an a-helix structure in the micro-
second-long trajectories (Fig. S1). Although the cytosolic
helix diffused through the viscous bilayer surface in the
microsecond timescale, we found that this domain of PLB
did not interact with SERCA in the trajectories (Fig. 2 C).
This finding agrees with solid-state NMR spectroscopy ex-
periments (22). The polar angle between the TM and cyto-
solic helices of PLB calculated over the combined threeFIGURE 2 Structural characteristics of PLB in the complex. (A) Ca
RMSFs of PLB calculated from each independent MD trajectory. Brackets
show the location of the cytosolic and TM helices of PLB. (B) Interactions
between the TM domains of SERCA (surface representation) and PLB
(cartoon representation) in the crystal and MD structures. PLB is colored
in magenta. Residues of PLB that are important for inhibition are shown
as white sticks. These residues are located at the SERCA-PLB interface.
TM helices of SERCA that are directly involved PLB binding (TM2
(blue), TM4 (cyan), TM6 (orange), and TM9 (red)) are shown. (C) Cartoon
representation of the structural ensembles of SERCA-PLB averaged over
all three MD trajectories. SERCA and PLB are color-coded as indicated
in Fig. 1. To see this figure in color, go online.
Phospholamban Regulation of SERCA 1701trajectories is 90 5 20, demonstrating that the cytosolic
helix is in contact with the surface of the lipid bilayer in
all trajectories.Comparison between structural ensembles of
PLB-bound, E1, and E2 SERCA
We used cPCA to determine whether SERCA-PLB proton-
ated at E771 belongs to the continuum of E1 or E2 struc-
tures. We found that the structural changes observed in
x-ray structures are well described within the first two prin-
cipal components, PC1 and PC2. A 2D projection onto PC1
and PC2 revealed the presence of a single cluster containing
all seven crystal structures and three clusters of E1 struc-
tures (Fig. 3).
Although a direct comparison between SERCA-PLB and
crystal structures could be sufficient to determine whether
the complex falls in or near E1 or E2, such an approach
could provide incomplete, if not inaccurate, information.
For example, recent studies have shown that E1, and to a
lesser extent E2, cannot be represented as single structures,
because SERCA is structurally very flexible in solution
(64,66,67,69). Therefore, we performed a cPCA of ensem-
bles of both x-ray and MD structures of E1 and E2. We
generated the MD ensemble of E1 structures by combining
three MD trajectories of metal-ion-bound E1 (E1,Ca2þ,
E1,Kþ, and E1,Mg2þ) into a single trajectory. These trajec-
tories were generated in previous studies performed by our
group (64,66). In addition, we performed three 1 ms MD
simulations of E2 starting from three different crystal struc-
tures of SERCA in this state. We found that despite the rela-
tive flexibility of the cytosolic headpiece, the structure of E2
remained unchanged in the MD trajectories (Fig. S5). This
finding agrees with previous studies showing that proton-
ation of residues E309, E771, and E908 is sufficient to sta-
bilize the E2 state (60,63). We found that the structural data
from MD simulations provide a link between different crys-
tal structures of E1, as well as a more accurate visualization
of the structural dynamics of this state at physiological con-FIGURE 3 Comparison of the SERCA-PLB ensembles with the crystal
and MD structures of E1 and E2. Projection of the first two principal com-
ponents obtained from the cPCA performed on x-ray and MD ensembles of
E1 and E2. The ensemble of SERCA-PLB is shown in magenta. PDB codes
are used to indicate the location of open (PDB: 1SU4), partially open (PDB:
3W5B), and closed (PDB: 1VFP) structures of E1 SERCA. Each point rep-
resents either a crystal structure or a conformation extracted from the trajec-
tories at time intervals of 0.01 ms. To see this figure in color, go online.ditions (Fig. 3). Likewise, we found that E2 populates an
ensemble of relatively flexible structures, and that crystal
structures represent only one possible conformation of E2
in solution (Fig. 3).
The cPCA showed that, despite being protonated at E771,
PLB-bound SERCA does not fall within the structural space
covered by E2. Instead, we found that the structural
ensemble of SERCA-PLB in each independent trajectory
falls within the E1 structural space defined by both MD
and crystal structures (Fig. 3, magenta). Together with the
pKa calculations, this structural analysis indicates that
PLB-bound SERCA represents an E1 state of the pump pro-
tonated at residues E771 and E908. We designate this state
as E1,Hþ771-PLB.Water access to the cytosolic pathways of
E1,HD771-PLB
Bublitz et al. (30) recently analyzed water accessibility in
high-resolution crystal structures of SERCA and suggested
that the ion-exchange mechanism in the pump includes
two pathways that connect the transport sites with the
cytosol: 1) an N-path, formed by TM helices TM1, TM2,
TM4, and TM6, which is primarily used for metal ion bind-
ing to the transport sites; and 2) a C-path formed by TM5,
TM6, TM7, TM8, and TM10, which is used for Hþ release
from the transport sites to the cytosol after the E2-to-E1
transition of the pump (30). Analysis of the average water
density calculated using MD trajectories showed that,
except for E1,2Ca2þ, where transport sites are almost
entirely shielded from bulk water (70), E1 is characterized
by an open N-path and a closed C-path (Fig. 4 A);
conversely, E2 is characterized by a completely open C-
path and a partially open N-path (Fig. 4 B). However, we
found that metal ions cannot access the transport sites of
E2 despite the presence of a partially open N-path. In addi-
tion, we found that the C-path in E2 does not bind metal
ions, and the path is occupied by water molecules only.
These findings indicate that the C-path of SERCA is used
exclusively for Hþ countertransport through a chain of
hydrogen-bonded water molecules (water wires (71)).
To determine whether protonation of E771 affects water
accessibility in the N- and C-paths, we calculated the
average water density in the trajectories of E1,Hþ771-PLB
(Fig. 4 C) and compared it with that of E2 and E1. We found
that the transport sites of E1,Hþ771-PLB are connected to
the cytosol through a path filled by water molecules, indi-
cating the presence of an open N-path characteristic of other
E1 intermediates (e.g., E1,2Kþ and E1,Mg2þ). The density
maps also revealed the presence of water molecules in
the C-path of E1,Hþ771-PLB (Fig. 4, B and C). However,
it is unlikely that the partially accessible C-path of
E1,Hþ771-PLB is used for H
þ countertransport as in E2,
for two reasons: 1) unlike E2, the cytosolic side of the C-
path is completely sealed in E1,Hþ771-PLB (Fig. 4, B andBiophysical Journal 108(7) 1697–1708
FIGURE 4 Water density maps of E1, E2, and E1,Hþ771-PLB. (A) Water
density map of E1 SERCA in various metal-bound states. (B) Water density
of E2 SERCA. (C) Water density calculated for each individual MD trajec-
tory of E1,Hþ771-PLB. The blue surface represents the average weighted
atomic density of water molecules using a grid resolution of 0.1 nm. The
green and red boxes show the location of the cytosolic N-path and C-
path, respectively. SERCA is shown as gray ribbons. To see this figure in
color, go online.
1702 Espinoza-Fonseca et al.C), and 2) the water wire necessary for Hþ translocation
does not exist in E1,Hþ771-PLB (Fig. S6). These findings
indicate that the complex does not show E2-like structural
characteristics as was suggested in a previous study (26).
Instead, it is likely that PLB-induced, temporary structural
distortions in the transport sites result in water molecules
entering the C-path of E1,Hþ771-PLB.FIGURE 5 Metal-ion interactions in the transport sites of E1,Hþ771-
PLB. (A) Location of the nine different positions occupied by Kþ (yellow
spheres) in the transport sites of E1,Hþ771-PLB; each position is labeled
from 1 to 9. The dashed circles show the approximate location of the trans-
port sites I and II. TM helices are represented by gray ribbons and cation-
binding residues are shown as sticks. (B) Percentage of time Kþ spends in
each position shown in (A). Data are presented as the mean5 SE (n ¼ 3).
(C) Distance distributions between residue pairs E771Ca-D800Ca, E771Ca-
G801Ca, and E771Cd-D800Cg. Distance distributions of E1,2K
þ (upper
panel) were calculated from a 1 ms trajectory reported recently by our group
(64). Distance distributions of E1, Hþ771-PLB (lower panel) were calcu-
lated by combining all three trajectories of the complex. To see this figure
in color, go online.Metal-ion binding in the transport sites of
E1,HD771-PLB
Analysis of water accessibility showed that unlike E2, the
transport sites of E1,Hþ771-PLB are completely exposed
to the cytosol (Fig. 4 C). This finding suggests that water
and metal ions can access the transport sites in the complex.
Therefore, we analyzed the metal-ion occupancy in the
transport sites of E1,Hþ771-PLB. Quantitative analysis
revealed that the transport sites of E1,Hþ771-PLB are occu-
pied by one or two Kþ ions for 77%5 1% and 5%5 2% of
the time, respectively. In contrast, the transport sites are
metal-ion free only 16% 5 5% of the time. We found that
the transport sites of E1,Hþ771-PLB do not bind Mg
2þ at
physiological ion concentrations, in agreement with x-ray
crystallography (26).
Next, we investigated the Kþ interactions with the
transport sites of E1,Hþ771-PLB. We found that K
þBiophysical Journal 108(7) 1697–1708ions bind to nine different positions in the transport sites
of E1,Hþ771-PLB (Fig. 5 A), and that the preference for
a single site is variable in the trajectories (Fig. 5 B). For
instance, Kþ interacts with residue D800 (sites 1, 2, and
8) for at least 40% of the time. These findings indicate
that metal ions bind in the transport sites of E1,Hþ771.
However, the electron density map showed that the com-
plex lacks metal ions bound to the transport sites (26).
We found that although the transport sites are occupied
by Kþ at least 80% of the time, the residence time of
Kþ in the positions shown in Fig. 5 A is %5 ns. This
value is much smaller than the residence times of Kþ
in apo E1 (>0.9 ms) (64), indicating that Kþ exchanges
frequently in the transport sites. Such a low residence
time explains the lack of a positive peak in the Fo  Fc
electron density map of the transport sites of PLB-bound
SERCA (26).
E1,Hþ771 binds K
þ, but is not able to produce compe-
tent transport-site geometries (Fig. S7). We analyzed the
structural changes in the transport sites induced by PLB
to determine why Kþ binding is insufficient to produce a
structural arrangement in the transport sites associated
with SERCA activation (64). Crystallographic data showed
that residue N34 of PLB, which plays an essential role in
SERCA inhibition (72), induces a deformation in the trans-
port sites though a network of intermolecular contacts
involving residues Q108 (TM2), G801 (TM8), and T805
Phospholamban Regulation of SERCA 1703(TM8) of SERCA (26). We analyzed hydrogen bonding by
N34 because it has been shown that this residue is directly
responsible for the SERCA inhibition (73), whereas the C-
terminus and the cytosolic helix are important for PLB
localization (74) and phosphorylation-dependent relief of
inhibition (21–24), respectively. We found that only inter-
actions N34-G801 and N34-T805 were present in more
than 80% of the simulation time in the trajectories, and
intermolecular contacts between N34 and Q108 were
only transiently present (Fig. S8; see also Fig. 2 B, with
TM2 in blue and TM8 in orange). To determine how inter-
actions N34-G801 and N34-T805 alter the geometry of the
transport sites, we calculated the interresidue distance be-
tween residues E771 and D800/G801. We found that
PLB binding resulted in an increase in the Ca-Ca distance
between residues E771 and D800/G801, which was 0.2 nm
longer than that found in E1,2Kþ (64) (Fig. 5 C, red and
blue lines). However, this relatively small change results in
a 0.35 nm separation between the carboxylic groups of
D800 and E771 (Fig. 5 C, green line). This structural
change prevents D800 from participating in the occlusion
of metal ions in site I (Fig. 5 A). Therefore, the local
structural changes induced by PLB do not block metal-
ion binding, but inhibit the formation of a competent trans-
port site I.
It was recently proposed that PLB binding to SERCA
facilitates the interaction between E771 and N796, which
results in the protonation of the former (26). To test this hy-
pothesis, we plotted the distance distributions of Cd atoms
between E771 and N796 (Fig. 6). In addition, we calculated
the distance cutoff at which E771 and N796 interact
through at least one hydrogen bond (dashed line, Fig. 6).
We found that this plot captures both the actual spatial
separation between these residues and the probability of
hydrogen-bond formation between E771 and N796. We
found that E771–N796 is in a dynamic equilibrium betweenFIGURE 6 Distance distributions between E771 and N796 in E1,Hþ771-
PLB. Cd-Cd distance distributions between residues E771 and N796 were
calculated for each trajectory (MD1–MD3) of E1,Hþ771-PLB. Distance
distributions were fitted to a two-Gaussian distribution. The dashed line in-
dicates the distance cutoff at which E771 and N799 are bound by at least
one hydrogen bond (R% 0.5 nm). Distances longer than this cutoff value
indicate the absence of a hydrogen bond. pKa values (mean5 SE) for E771
in the presence and absence of hydrogen bonds are shown in the plots. To
see this figure in color, go online.two populations. The first population (R < 0.51 nm) corre-
sponds to E771 and N796 interacting by at least one
hydrogen bond. The second population (R > 0.51 nm) rep-
resents a spatial separation where E771 and N796 no longer
form hydrogen bonds. In addition, pKa calculations showed
that E771 remains protonated even in the absence of
hydrogen bonds with N796 (Fig. 6). Additional calculations
showed that transient binding of a Kþ near E771 (e.g.,
position 3 in Fig. 5 A) does not decrease the pKa of this
residue. To explain why E771 remains protonated in the
SERCA-PLB complex, we calculated the pKa of E771 us-
ing a trajectory of E1,2Kþ (64). In the absence of PLB,
the pKa of E771 is 3.8 5 0.3, indicating that this residue
is deprotonated in E1,2Kþ. Closer inspection of the
metal-ion interactions in the transport sites revealed that
KI
þ simultaneously coordinates oxygen atoms from D800
and E771 in E1,2Kþ, but not in E1,Hþ771. Binding of
the first Ca2þ ion between E771 and D800 induces rotation
of TM6 and a side-chain swivel of E309 on TM4, thereby
forming the second Ca2þ-binding site (N796, D800, and
E309) and accounting for SERCA cooperative Ca2þ bind-
ing (48,49). These observations indicate that PLB-induced
structural alterations in the transport sites inhibits a metal
ion from simultaneously binding to both D800 and E771,
thus maintaining protonation of E771and preventing TM6
rotation.
To further support the observation that E771 must be
protonated in SERCA-PLB, we performed three additional
0.3 ms MD simulations: SERCA-PLB with E771 deproto-
nated, and SERCA without PLB with E771 protonated
and deprotonated. The simulation of SERCA-PLB with
E771 modeled as deprotonated showed that that proton
removal from E771 indeed decreases the pKa of this resi-
due to a mean value of 4.8, but ionization of E771 does
not alter the spatial separation between Cd and Cg of
E771 and D800, respectively (R ¼ 0.9 5 0.08 nm).
Furthermore, we found that deprotonation of E771 facili-
tates the stabilization of two Kþ ions bound to E771 and
D800 (Fig. S9). These Kþ ions have residence times in
the range of hundreds of nanoseconds, and probably longer.
This finding is in contrast to the electron density maps
showing that the transports sites, and in particular the re-
gion around E771 and D800, are metal-ion free in
SERCA-PLB. Upon removal of PLB, we found that the
pKa of E771 decreases to a mean value of 5.9. An addi-
tional MD simulation starting from a structure at the end
of this trajectory and with deprotonated E771 showed
that the transport sites adopt a competent structure charac-
teristic of apo E1 (RE771-D800 ¼ 0.61 5 0.05 nm; Fig. S9)
(64) and that the pKa of E771 further decreases to a value
of 3.7. Together, these sets of simulations strongly support
the following observations: 1) E771 is protonated in
SERCA-PLB, and 2) PLB is directly responsible for the
structural changes in the transport sites that promote pro-
tonation of E771 in the E1 state.Biophysical Journal 108(7) 1697–1708
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headpiece of E1,HD771-PLB
We next sought to determine the cytosolic headpiece
structure dynamics of E1,Hþ771. For this purpose, we
plotted the interdomain distance distributions of E1,Hþ771
and compared them against the crystal structures of
E1,2Ca2þ, E1,2Ca2þ,AMPPCP, and E1,Mg2þ (Fig. 7).
Interdomain distance distributions of N-A, N-P, and A-P
domains were calculated using Ca-Ca distances of the
following amino acid pairs: K515-T171 (N-A domains),
R489-E680 (N-P domains), and T171-E680 (A-P domains).
We tested one- and two-Gaussian distribution models for
each distance distribution, r(R), of each Ca-Ca distance
pair. We found that all distances fit very well to either a
one- or two-Gaussian distribution, with correlation coeffi-
cient values of R0.95 for all Gaussian distributions.
We found that interdomain distances K515-T171 (N-A
domains) in only one trajectory the complex (MD1) fit to
a single Gaussian distribution with mean ¼ 2.4 nm,
0.2 nm shorter than the distance calculated from the crystal
structure of E1,Mg2þ (Fig. 7 A, upper panel). The distance
distributions in trajectories MD2 and MD3 fit to a
two-Gaussian model, and the N-A domain distance of
E1,Mg2þ falls within these boundaries of the distributions
(Fig. 7 A, middle and lower panels). Except for trajectory
2 (Fig. 7 B, middle panel), the average geometry of the
N-P interface in the trajectories of E1,Hþ771-PLB is very
similar to the geometry observed in the crystal structure of
E1,Mg2þ (Fig. 7 B, upper and lower panels). The distanceFIGURE 7 Distance distributions between the N, A, and P domains of
E1,Hþ771-PLB. MD trajectories of E1,H
þ
771-PLB (magenta) were used
to calculate the Ca-Ca distance distribution between (A) residues K515
and T171 in N and A domains, (B) residues R489 and E680 in N and P do-
mains, and (C) residues T171 and E680 in A and P domains (A-P). For com-
parison, discrete distances for the same pairs of residues were calculated
from crystal structures of E1,Mg2þ (PDB: 3W5B in green), E1,2Ca2þ
(PDB: 1SU4 in blue), and E1,2Ca2þ,AMPPCP (PDB: 1VFP in purple).
To see this figure in color, go online.
Biophysical Journal 108(7) 1697–1708T171-E680 (A-P domains) of E1,Hþ771-PLB shows the
largest variability among the three independent trajectories
(Fig. 7 C). These findings indicate that E1,Hþ771-PLB
does not populate either a compact or an open headpiece
conformation in solution. Instead, we found that the head-
piece arrangement of E1,Hþ771-PLB populates a relatively
closed structure, which is not suitable for either ATP hydro-
lysis or nucleotide exchange (64,66). These findings com-
plement the cPCA analysis shown in Fig. 3, showing that
PLB shifts SERCA equilibrium toward a closed headpiece
structure.DISCUSSION
PLB populates an inhibited E1,HD771 state of
SERCA
In this work, we used protein pKa calculations and micro-
second MD simulations to show that PLB binding populates
a protonated E1 state of SERCA, E1,Hþ771. Several studies
have shown that PLB binds to SERCA throughout its cata-
lytic cycle (34,36,75), and that SERCA inhibition depends
on the structural shifts between the R and T states of PLB
(21–24). Therefore, it is possible that E1,Hþ771-PLB does
not represent the inhibited state of the complex, because
the cytosolic region of PLB was not resolved in the crystal
structure of the complex. However, we rule out this possibil-
ity for the following reasons: 1) The PLB mutant used to
obtain crystals of the complex, PLB4, was shown to bind
to SERCA with very high affinity, comparable to or even
greater than that of thapsigargin (TG) (25). However,
FRET experiments have shown that TG and Ca2þ decrease
the binding affinity of PLB (34). Therefore, E1,Hþ771-
PLB represents the high-affinity complex because the crys-
tal structure of SERCA-PLB4 was obtained in the absence
of TG and Ca2þ (26). 2) In a recent study (76), NMR resid-
ual dipolar couplings and restrained MD simulations
showed that residues A24–Q29 are completely unfolded in
the noninhibitory R state of PLB. However, the electron
density maps in the crystal structure of SERCA-PLB4 and
our MD simulations show that this segment folds as a stable
a-helix. This evidence indicates that E1,Hþ771-PLB repre-
sents the structure of the inhibited complex.PLB does not inhibit the E2-to-E1 transition of
SERCA
One of the most controversial issues in SERCA regulation is
whether PLB blocks the E2-to-E1 transition or traps the
pump in a metal-ion-bound E1 intermediate. The first hy-
pothesis suggests that PLB binds only to SERCA in E2
(17,77) or E2,ATP (16,25,26) states, and blocks the E2-
to-E1 transition of the pump. The second hypothesis, based
on crystallographic evidence, proposes that PLB binds to an
Mg2þ-bound E1 intermediate and blocks the progression of
Phospholamban Regulation of SERCA 1705the cycle toward E1~P,2Ca2þ,ADP (28,29). Bidwell et al.
(34) proposed a third scenario based on the results of
FRET experiments on rabbit ventricular myocytes. These
experiments showed that the SERCA-PLB complex is not
disrupted by elevations of cytosolic calcium during cardiac
contraction, suggesting that PLB remains bound to the
metal-ion-bound E1 state of the pump, albeit with lower
affinity (34). However, these experiments did not reveal
which step along the catalytic cycle is affected by PLB.
Our simulations showed that PLB does not inhibit the
E2-E1 transition, because the crystal structure of SERCA-
PLB represents an E1 state. This indicates that SERCA is
not locked in a dead-end E2 state (e.g., E2 bound to the
inhibitor TG), but has transitioned to E1. Our simulations
demonstrate that PLB binding populates an inhibited
E1,Hþ771 intermediate, indicating that PLB inhibition of
SERCA occurs primarily in the E1 state. Kinetics experi-
ments have shown that PLB interferes with binding of the
first (47) and second (46) Ca2þ ions to E1. Although our
simulations were performed in the absence of Ca2þ, they
provide an explanation for these experimental results: as
cytosolic Ca2þconcentration increases, it is possible that
the first Ca2þ binds to E1,Hþ771 near D800 in the transport
sites (Kþ in position 1, Fig. 5 A). However, the structural
distortion in the transport sites induced by PLB inhibits
Ca2þ from interacting with both D800 and E771, which is
required for the formation of a competent transport site I
(64). The inability of transport site I to adopt a competent
geometry will inevitably result in an altered geometry of
the site II. Therefore, the PLB-induced structural alterations
in the transport sites explain the altered rates of binding of
the second Ca2þ ion (46). We propose that PLB populates
an inhibited E1 state that interferes with the formation of
a catalytically competent E1 state of the pump.Functional role of E1,HD771 in the mechanism of
SERCA regulation by PLB
Our findings suggest that PLB binding does not inhibit the
E2-to-E1 transition of SERCA, but populates an inhibited
E1,Hþ771 state of the pump. What is the functional impor-
tance of regulating SERCA activity through changes in
protonation of the E1 state? E1 exists as a broad ensemble
of structures separated by small energy barriers, and ligand
binding (Ca2þ, Kþ, and Mg2þ) allosterically shifts this
equilibrium toward an open or closed structure within the
E1 continuum (28,29,64,66). Functional assays on native
SERCA showed that activation of the pump by Ca2þ re-
quires a pH-dependent, rate-limiting transition that is
slower at acid than at alkaline pH (E2-to-E1 transition)
(60). Based on these observations, it was proposed that
activation by Ca2þ is easier if the enzyme resides in the
E1 state rather than in a protonated E2 state (60). Indeed,
coarse-grained simulations showed that the E2-to-E1 transi-
tion has a very large energy barrier (78). Alternatively,protonation/deprotonation of E1 offers other functional
advantages. For instance, protonation can change the
conformation and activity of a protein in a specific manner
(79). In addition, protonation can impair regulation modes,
including specificity, allostery, and cooperativity (79).
Indeed, we found that PLB controls the headpiece dynamics
of E1,Hþ771 and populates a headpiece structure that is not
suitable for nucleotide binding and exchange (Fig. 7).
Deprotonation of E771 after relief of SERCA inhibition
should induce a rapid shift in the continuum of E1 struc-
tures to populate an open state, which is necessary for
nucleotide exchange (64), and a productive closed state
upon Ca2þ binding (66). Therefore, efficient and rapid regu-
lation of SERCA activity is achieved by creating additional
biochemical states in the E1 state, which serves as a kinetic
trap in the structural transitions of E1. Hence, E1,Hþ771 en-
sures that the structural transitions associated with SERCA
activation are temporarily depressed, but not abolished,
at normal physiological conditions. We suggest that this
mechanism of SERCA regulation by PLB results in both
a rapid improvement of SR Ca2þ loading during diastole
(relaxation) and higher Ca2þ availability during systole
(contraction).CONCLUSION
We have used protein pKa calculations and all-atom micro-
second MD simulations to determine whether PLB inhibits
the E1 or E2 states of SERCA. Our simulations not only
showed that the inhibitory conformation of PLB binds to
E1 SERCA but also revealed a novel (to our knowledge)
protonated E1 state, designated as E1,Hþ771. We found
that in the absence of Ca2þ, Kþ ions bind to the transport
sites of E1,Hþ771, albeit transiently and nonspecifically.
However, a PLB-induced structural deformation around res-
idues D800/G801 renders SERCA incapable of producing
competent transport sites. These findings indicate that
PLB does not regulate SERCA by blocking the E2-to-E1
transition. Instead, PLB binding populates a novel (to our
knowledge) E1,Hþ771 state that controls headpiece dy-
namics and depresses the structural transitions that are
necessary for Ca2þ-dependent activation of SERCA. Hence,
PLB is an effector that introduces modifications in the en-
ergy landscape of the E1 state. We propose that E1,Hþ771
is an intermediate that is necessary for rapid Ca2þ transport
after relief of SERCA inhibition. We conclude that the effi-
cient PLB-mediated regulation of SERCA activity in the
heart results from structural transitions that occur primarily
in the E1 state of the pump.SUPPORTING MATERIAL
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